Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Aranzazu Fernández-Martínez
Based on 3 articles published since 2009
(Why 3 articles?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 3 published articles on Melanoma from 2009 through 2019, it is not possible for Expertscape to reliably rate Aranzazu Fernández-Martínez's expertise on this topic.

Aliases Fernandez-Martinez, A   ·   Fernández-Martínez, Aranzazu
Work Locations
Details
Most likely:    Universitat de Barcelona      
2017
  • Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Pubmed 27147251
2016
  • Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain. · Targeted Therapeutics & Translational Genomics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain. · Pubmed 27581765
  • Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain. · Translational Genomics & Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Dermatology Department, Hospital Clinic Barcelona, Barcelona, Spain. · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Spain, Madrid, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27115320
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Aranzazu Fernández-Martínez in 2009-2019 about Melanoma:

  • Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma. 2017
  • Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma. 2016
  • Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab. 2016
Show List of Full Article Records
Google Searches

Learn more about Aranzazu Fernández-Martínez using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat de Barcelona
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat de Barcelona
2017
  • Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Pubmed 27147251
2016
  • Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain. · Targeted Therapeutics & Translational Genomics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain. · Pubmed 27581765
  • Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain. · Translational Genomics & Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Dermatology Department, Hospital Clinic Barcelona, Barcelona, Spain. · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Spain, Madrid, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27115320
Yearly article counts 00120000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.